Mitchell McLeod Pugh & Williams’s Biogen BIIB Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-675	Closed	-$234K	–	222
2021 Q2	$234K	Buy	+675	New	+$204K	0.09%	206
2020 Q2	–	Sell	-655	Closed	-$207K	–	187
2020 Q1	$207K	Buy	+655	New	+$199K	0.16%	159
2018 Q4	–	Sell	-590	Closed	-$208K	–	166
2018 Q3	$208K	Sell	590 -145	-20%	-$49.9K	0.14%	173
2018 Q2	$213K	Hold	735	–	–	0.15%	168
2018 Q1	$201K	Hold	735	–	–	0.14%	174
2017 Q4	$234K	Hold	735	–	–	0.16%	167
2017 Q3	$230K	Buy	+735	New	+$218K	0.17%	162
2017 Q2	–	Sell	-735	Closed	-$201K	–	170
2017 Q1	$201K	Hold	735	–	–	0.16%	164
2016 Q4	$208K	Hold	735	–	–	0.17%	161
2016 Q3	$230K	Buy	+735	New	+$218K	0.2%	144
2016 Q1	–	Sell	-1,335	Closed	-$409K	–	156
2015 Q4	$409K	Hold	1,335	–	–	0.41%	93
2015 Q3	$390K	Hold	1,335	–	–	0.4%	89
2015 Q2	$539K	Hold	1,335	–	–	0.5%	75
2015 Q1	$564K	Sell	1,335 -60	-4%	-$23.6K	0.51%	74
2014 Q4	$474K	Buy	+1,395	New	+$451K	0.44%	82

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mitchell McLeod Pugh & Williams's BIIB Position: Q3 2021 in Review

Mitchell McLeod Pugh & Williams sold out of Biogen (BIIB) in Q3 2021, closing a stake of 675 shares — an estimated $234K sold.

Mitchell McLeod Pugh & Williams first reported a position in BIIB in Q4 2014 and held it in 15 quarters. The position peaked at $564K in Q1 2015. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Mitchell McLeod Pugh & Williams reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
Mitchell McLeod Pugh & Williams sold 675 Biogen shares in Q3 2021, an estimated $234K.
Mitchell McLeod Pugh & Williams first reported a position in Biogen in Q4 2014 and held it in 15 quarters.
Mitchell McLeod Pugh & Williams's Biogen position peaked at $564K in Q1 2015.
1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q3 2021, filed 8 Nov 2021.